JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 33 No. 8 1472-1477
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffman, J. M.
Right arrow Articles by Phelps, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffman, J. M.
Right arrow Articles by Phelps, M. E.

The Effects of Carbidopa Administration on 6-[18F]Fluoro-L-DOPA Kinetics in Positron Emission Tomography

John M. Hoffman*, William P. Melega, Thomas C. Hawk, Scott C. Grafton, Andre Luxen{dagger}, D. Kirk Mahoney, Jorge R. Barrio, Sung-Cheng Huang, John C. Mazziotta and Michael E. Phelps

Division of Nuclear Medicine and Biophysics, Departments of Radiological Sciences, Pharmacology and Neurology and Laboratory of Nuclear Medicine, Laboratory of Biomedical and Environmental Sciences, UCLA School of Medicine, University of California at Los Angeles, Los Angeles, California

Correspondence: For reprints contact: *John M. Hoffman, Section of Nuclear Medicine, Department of Radiology, Box 3808, Duke University Medical Center, Durham, NC 27710.

ABSTRACT

Carbidopa (L-{alpha}-hydrazino-{alpha}-methyl-b-(3,4-dihydroxyphenyl) propionic acid is a known inhibitor of aromatic amino acid decarboxylase. In both humans and monkeys, we studied the effects of carbidopa on plasma and brain kinetics of 6-[18F] fluoro-L-DOPA (FDOPA), an analog of L-DOPA used for PET studies of the central dopaminergic system. Pretreatment with carbidopa resulted in increases in the plasma levels of FDOPA and 3-O-methyl-6-[18F]fluoro-L-DOPA (3-OMFD). Total striatal and cerebellar activities measured with PET were also increased. Furthermore, increases observed in the specific striatal activity (striatum minus cerebellum total activity) were correlated with increases in the plasma FDOPA curve. Carbidopa pretreatment did not affect the influx rate constant (K) for FDOPA from plasma to striatum in humans as determined by Patlak graphical analysis. Thus, an increase in measured striatal tomographic activity was secondary to the increase in plasma FDOPA levels rather than as a result of changes in the FDOPA influx rate constant.

FOOTNOTES

* Current address: Section of Nuclear Medicine, Department of Radiology, Box 3808, Duke University Medical Center, Durham, NC 27710.

{dagger} Current address: Cliniques Universitaire, De Bruxelles, Hospital Erasme, Route De Lennik 808, B-1070 Bruxelles, Belgium.




This article has been cited by other articles:


Home page
JCOHome page
S. Kauhanen, M. Seppanen, and P. Nuutila
Premedication With Carbidopa Masks Positive Finding of Insulinoma and {beta}-Cell Hyperplasia in [18F]-Dihydroxy-Phenyl-Alanine Positron Emission Tomography
J. Clin. Oncol., November 10, 2008; 26(32): 5307 - 5308.
[Full Text] [PDF]


Home page
JNMHome page
P. L. Jager, R. Chirakal, C. J. Marriott, A. H. Brouwers, K. P. Koopmans, and K. Y. Gulenchyn
6-L-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications
J. Nucl. Med., April 1, 2008; 49(4): 573 - 586.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. J.L.M. Timmers, M. Hadi, J. A. Carrasquillo, C. C. Chen, L. Martiniova, M. Whatley, A. Ling, G. Eisenhofer, K. T. Adams, and K. Pacak
The Effects of Carbidopa on Uptake of 6-18F-Fluoro-L-DOPA in PET of Pheochromocytoma and Extraadrenal Abdominal Paraganglioma
J. Nucl. Med., October 1, 2007; 48(10): 1599 - 1606.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. L. Whone, D. L. Bailey, P. Remy, N. Pavese, and D. J. Brooks
A Technique for Standardized Central Analysis of 6-18F-Fluoro-L-DOPA PET Data from a Multicenter Study
J. Nucl. Med., July 1, 2004; 45(7): 1135 - 1145.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. E. Ahlskog
Slowing Parkinson's disease progression: Recent dopamine agonist trials
Neurology, February 11, 2003; 60(3): 381 - 389.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1992 by the Society of Nuclear Medicine.